An Improved Bicistronic CD20/tCD34 Vector for Efficient Purification and In Vivo Depletion of Gene-Modified T Cells for Adoptive Immunotherapy
Molecular Therapy2010Vol. 18(7), pp. 1330–1338
Citations Over TimeTop 22% of 2010 papers
Isabel Vogler, Sebastian Newrzela, Sylvia Hartmann, Nadine Schneider, Dorotheé von Laer, Ulrike Koehl, Manuel Grez
Related Papers
- → AAV vectors: is clinical success on the horizon?(2000)301 cited
- The progress of retroviral vector in hemophilia A gene therapy(2001)
- Progress in the Nonviral Vectors of Gene Therapy(2005)
- → Adoptive cellular immunotherapy for cancer(2013)
- → Adoptive Immunotherapy(2009)